NRC Health Common Stock (NRC)

Price$19.14

Value ScoreD

Growth ScoreD

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)4.73%

Price vs S&P 500 (4W)2.09%

VGM Score40.61

Market Capitalization$431.35M

P/E Ratio (Annual)37.19x

Indicated Dividend Yield (Annual)3.24%

All Metrics

P/CF (Annual)16.31x

Book Value / Share (Quarterly)$0.60

P/TBV (Annual)36.15x

Indicated Dividend (Annual)$0.64

Revenue Growth (3Y)-3.23%

Cash Flow / Share (Quarterly)$0.77

Payout Ratio (TTM)99.53%

Price vs S&P 500 (YTD)-6.19%

Gross Margin (TTM)61.80%

Net Profit Margin (TTM)6.52%

EPS (TTM)$0.41

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$0.41

Revenue Growth (5Y)0.61%

EPS (Annual)$0.52

Dividend / Share (Annual)$0.48

ROI (Annual)12.47%

Gross Margin (Annual)61.88%

Net Profit Margin (5Y Avg)18.58%

Cash / Share (Quarterly)$0.11

P/E Basic Excl Extra (TTM)47.74x

Revenue Growth QoQ (YoY)3.73%

EPS Growth (5Y)-18.62%

P/E Normalized (Annual)37.19x

ROA (Last FY)8.60%

Revenue Growth TTM (YoY)-1.88%

EBITD / Share (TTM)$1.25

ROE (5Y Avg)62.71%

Operating Margin (TTM)14.11%

Cash Flow / Share (Annual)$0.70

P/B Ratio31.96x

P/B Ratio (Quarterly)28.62x

Net Income / Employee (Annual)$32,500

EV / Revenue (TTM)3.66x

Net Interest Coverage (TTM)4.84x

ROA (TTM)6.61%

EPS Growth QoQ (YoY)-41.64%

EV / EBITDA (TTM)18.38x

EPS Incl Extra (Annual)$0.52

Current Ratio (Annual)0.55x

Quick Ratio (Quarterly)0.37x

3-Month Avg Trading Volume0.11M

52-Week Price Return33.19%

EV / Free Cash Flow (Annual)32.19x

P/E Incl Extra (TTM)47.74x

Revenue / Employee (TTM)$388,400

Tangible BV / Share (Quarterly)$0.50

P/S Ratio (Annual)3.14x

Asset Turnover (Annual)1.02x

52-Week High$22.79

Operating Margin (5Y Avg)26.53%

EPS Excl Extra (Annual)$0.52

CapEx CAGR (5Y)21.88%

Tangible BV CAGR (5Y)-28.49%

26-Week Price Return12.65%

Quick Ratio (Annual)0.45x

13-Week Price Return36.32%

Total Debt / Equity (Annual)5.65x

Current Ratio (Quarterly)0.52x

Enterprise Value$506.84M

Revenue / Share Growth (5Y)3.41%

Asset Turnover (TTM)1.01x

Book Value / Share Growth (5Y)-24.57%

Revenue / Employee (Annual)$384,800

Pretax Margin (Annual)12.99%

Cash / Share (Annual)$0.18

3-Month Return Std Dev43.66%

Gross Margin (5Y Avg)62.26%

Net Income / Employee (TTM)$25,300

EBITDA CAGR (5Y)-9.66%

EBITDA Interim CAGR (5Y)-11.74%

ROE (Last FY)82.92%

Net Interest Coverage (Annual)3.91x

EPS Basic Excl Extra (Annual)$0.52

P/FCF (TTM)19.99x

Receivables Turnover (TTM)12.42x

EV / Free Cash Flow (TTM)29.08x

Total Debt / Equity (Quarterly)5.78x

EPS Incl Extra (TTM)$0.41

Receivables Turnover (Annual)12.22x

ROI (TTM)9.48%

Dividend Growth Rate (5Y)2.80%

P/S Ratio (TTM)3.11x

Pretax Margin (5Y Avg)24.76%

Revenue / Share (Annual)$6.13

Tangible BV / Share (Annual)$0.52

Free OCF CAGR (5Y)-15.55%

Price vs S&P 500 (52W)8.83%

P/E Ratio (TTM)47.74x

EPS Growth TTM (YoY)-60.19%

Year-to-Date Return1.97%

5-Day Price Return-5.48%

EPS Normalized (Annual)$0.52

ROA (5Y Avg)20.16%

Net Profit Margin (Annual)8.44%

Month-to-Date Return-2.00%

Cash Flow / Share (TTM)$1.40

EBITD / Share (Annual)$1.35

EPS Growth (3Y)-25.78%

Operating Margin (Annual)16.44%

LT Debt / Equity (Annual)5.36x

P/CF (TTM)15.99x

ROI (5Y Avg)28.38%

P/E Excl Extra (TTM)47.74x

LT Debt / Equity (Quarterly)5.48x

EPS Basic Excl Extra (TTM)$0.41

P/TBV (Quarterly)34.09x

Payout Ratio (Annual)94.64%

P/B Ratio (Annual)30.40x

Dividend / Share (TTM)$0.52

Pretax Margin (TTM)10.46%

Book Value / Share (Annual)$0.62

Price vs S&P 500 (13W)28.07%

Net Margin Growth (5Y)-21.31%

Dividend Yield (TTM)2.74%

Beta0.39x

P/FCF (Annual)27.40x

Revenue / Share (TTM)$6.33

ROE (TTM)57.26%

52-Week Low$11.01

vGradeD

gGradeD

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.21est. —

Analyst Recommendations

Sep 2021

Oct 2021

Nov 2021

Dec 2021

2.25

Industry Peers — R&D — Physical Sciences(15)

Symbol	Value Score	Growth Score	Momentum Score	Price
NRCNRC Health Common Stock	D	D	B	$19.14
IQVIQVIA Holdings Inc.	C	B	C	$183.45
INCYIncyte Genomics Inc	C	A	B	$102.38
MEDPMedpace Holdings, Inc. Common Stock	D	A	B	$454.25
ICLRIcon Plc	C	C	B	$149.45
CRLCharles River Laboratories International, Inc.	D	D	B	$181.34
ABSIAbsci Corporation Common Stock	F	F	A	$6.40
OABIOmniAb, Inc. Common Stock	D	C	A	$2.48
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.14
ONMDOneMedNet Corp Class A Common Stock	D	C	B	$0.68
BIAFbioAffinity Technologies, Inc. Common Stock	C	F	B	$1.73

About

National Research Corp provides analytics and insights that help healthcare providers, payers, and other healthcare organizations measure and improve patient and employee experiences while increasing engagement and loyalty. The company operates primarily in the United States and Canada, with the majority of its revenue derived from the U.S. market.